Filing Details
- Accession Number:
- 0001140361-21-036421
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-03 16:26:44
- Reporting Period:
- 2021-11-01
- Accepted Time:
- 2021-11-03 16:26:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1218860 | J Steinar Engelsen | 700 Us Highway 202/206 Bridgewater NJ 08807 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-01 | 14,235 | $30.14 | 320,802 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This is the weighted average sales price representing the shares purchased at prices ranging from $30.05 to $30.25 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.